Midi Health

Abby (right) came across a LinkedIn post from Self-Insured Schools of California Executive Director of Health Benefits, Nicole Mata — and it changed her life. Abby felt desperate after a doctor dismissed her menopause symptoms as “all in her head." 👂 She wasn't being listened to. ⏳ There were long wait times for care in her area. 🤷♀️ And she wasn't sure she could swing more time off from work to see the several specialists she thought she'd need to find answers. Learning that our expert care was covered under her health insurance, Abby met with a clinician and says she saw benefits almost immediately. And the post from Nicole that led her to Midi? "Heaven sent," Abby says. Yesterday, Abby told her story at SISC's 2025 Healthcare Symposium. Joined by Midi Chief Clinical Officer Mindy Goldman (left), they shared why women shouldn't wait to get the care they need—and the impact managers can have on women's lives when they connect them to it.

Testosterone sounds scary for many women - and we are here to demystify it at Midi Health. Testosterone fluctuations don’t just impact men. By menopause, women can lose up to 50%** of their natural testosterone. That drop can contribute to: Decreased libido Low energy and fatigue Brain fog and mood swings Muscle and bone weakness Women are often scared to try testosterone - Many fear developing male-like physical traits, such as a deeper voice, excessive body or facial hair, and male-pattern baldness. But this does not happen if you monitor the dosage and don't overdo it. Also, we strongly suggest avoiding pellets and using a cream formulation instead so you can control dosing. It was great for Midi Health to be featured in this NYT article on testosterone - and you may want to try it - you can see me here demonstrating how to apply! https://lnkd.in/gDpSXUei

There’s a hormone care gap in the U.S., and we’re working to close it. Last week in NYC we kicked off the launch of Midi’s testosterone therapy with voices shaping the conversation: Joanna Strober, CEO & Co-founder of Midi Health, Tamsen Fadal, Jenna Bush Hager & Midi Chief Medical Officer Kathleen Jordan, MD. Midi now prescribes testosterone in 12 states* with plans to expand as individual state regulations allow. Learn more at: joinmidi.com/testosterone *AZ, CA, DC, FL, IL, MA, MD, NY, OH, TX, UT, and VA. Compounded drug products are not FDA-approved. FDA does not evaluate compounded products for safety, effectiveness, or quality. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate.

⚕️CLINICIANS⚕️ We're so glad so many of you took us up on the chance to connect with Midi's chief clinical officer and menopause+cancer expert Dr. Mindy Goldman during our clinical webinar last week. If you missed it, here's a clip from that engaging conversation. Be sure join us for our two remaining clinical webinars of the year. 👉 Next up: Hormone Therapy 101 on November 13 at 5 pm EST 🗓️ See the full line-up and register here: https://lnkd.in/e2Fh4VeT

CNBC and Ian Thomas are highlighting Midi Health’s testosterone therapy for women  — a step toward closing a decades‑long gap in hormone care. We’re excited to see more conversation and attention on real solutions that help women power through perimenopause and menopause with confidence. Read the full story 👇 https://lnkd.in/gzT69XWq

Women have been excluded from testosterone therapy for decades — and the fact there’s still no FDA-approved option in the U.S. is a glaring inequity. We’re changing that. Midi now offers testosterone therapy designed for women, with personalized clinician care, adjustable dosing, and insurance coverage. “We are disrupting that system by expanding access and fighting for the change women deserve," says Joanna Strober, CEO & Co-founder of Midi Health. Midi now prescribes testosterone in 12 states* with plans to expand as individual state regulations allow. https://lnkd.in/gQHudX2y *AZ, CA, DC, FL, IL, MA, MD, NY, OH, TX, UT, and VA. Compounded drug products are not FDA-approved. FDA does not evaluate compounded products for safety, effectiveness, or quality. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate.

Working with menopause symptoms can be like running a daily obstacle course.🏃♀️ Help women clear the path ahead. 🛣️ And then, watch them SHINE.🌟 Check out recommendations from Midi and workforce strategy firm The Fifth Trimester, and see what women who got the right care said about how it changed the way they show up on the job: https://lnkd.in/eVF4ptwh Lauren Smith Brody

Fresh from The Menopause Society’s 2025 Annual Meeting, Dr. Mindy Goldman, Midi’s Chief Clinical Officer, is sharing her top takeaways. Her message is clear: Women’s health deserves urgency, unity, and action. #WomensHealth #Menopause #MidiHealth

At Midi Health we are creating a healthcare home for women… and a great business as well. If this means millions of women get the care they need… we all win.

⚕️CLINICIANS⚕️ Next week, Dr. Mindy Goldman is sharing evidence-based strategies for managing menopause symptoms in patients with a history of cancer in a special clinician-to-clinician webinar. Don't miss this important conversation with Midi's Chief Clinical Officer and Director of our Survivorship Program, a first-of-its-kind, evidence-based program dedicated to providing cutting-edge menopause care for cancer survivors and women at high-risk for the disease (e.g., those with genetic mutations predisposing to cancer, breast atypia on biopsy, and DCIS). Register to attend or to get access to the recording: https://lnkd.in/erM_ibPg #oncology #breastcancer #survivorship #menopause #clinicalwebinar